The Society of Hospital Pharmacists of Australia is the first pharmacist member organisation to join the Choosing Wisely Australia initiative, coordinated in Australia by NPS MedicineWise.
SHPA will partner with Choosing Wisely Australia, leading medical colleges and consumer groups in the national initiative. The goal is for clinicians to improve the quality of health care; SHPA will focus on the appropriate and high quality evidence-based use of medicines.
Choosing Wisely is a global initiative that aims to reduce medical tests, treatments and procedures of proven low value.
Choosing Wisely Australia launched in April 2015 with the release of lists of tests, treatments and procedures that clinicians and consumers should question.
These lists of low value tests, treatments and procedures were developed by five specialist medical organisations, with the aim of generating conversations between the clinicians and consumers regarding appropriate and necessary treatment.
Federal President Professor Michael Dooley will represent SHPA on the Choosing Wisely Australia Representative Panel.
“In the coming months we will seek input from our members to develop a series of evidence-based statements focusing on the use of medicines and the role of pharmacists in supporting the quality use of medicines,” he says.
“These statements will be released in the second Choosing Wisely launch—early in 2016.
“SHPA strongly supports evidence-based decision making so we are pleased to champion the recommendations made through Choosing Wisely Australia.
“Reinforcing the evidence and improving the quality use of medicines is the cornerstone of pharmacy practice, particularly in hospitals.
‘Four of the recent recommendations from the Royal Australian College of General Practitioners relate to the use of medicines.
“This highlights the important role for pharmacists in supporting this initiative – in having the conversations with patients and with prescribers when evidence does not support the use of a medicine.”